enVVeno Medical Corp (NVNO) Shareholder Equity
- 2026-06-30: Additional Paid in CapitalUSD $199.45M; Retained Earnings (Accumulated Deficit)USD $-178.78M; Stockholders' Equity Attributable to ParentUSD $20.67M; APIC, Share-based Payment Arrangement, Increase for Cost RecognitionUSD 3 month · $397.00K.
- 2026-03-31: Additional Paid in CapitalUSD $198.92M; Retained Earnings (Accumulated Deficit)USD $-175.18M; Stockholders' Equity Attributable to ParentUSD $23.75M; APIC, Share-based Payment Arrangement, Increase for Cost RecognitionUSD 3 month · $467.00K.
- 2025-12-31: Additional Paid in CapitalUSD $198.46M; Retained Earnings (Accumulated Deficit)USD $-171.33M; Stockholders' Equity Attributable to ParentUSD $27.13M; APIC, Share-based Payment Arrangement, Increase for Cost RecognitionUSD 12 month · $3.42M.
- 2025-09-30: Additional Paid in CapitalUSD $197.04M; Retained Earnings (Accumulated Deficit)USD $-167.59M; Stockholders' Equity Attributable to ParentUSD $29.45M; APIC, Share-based Payment Arrangement, Increase for Cost RecognitionUSD 3 month · $688.00K.
enVVeno Medical Corp Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Additional Paid in Capital USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Stock Split USD | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Adjustments to Additional Paid in Capital, Warrant Issued USD |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $199.45M | $-178.78M | $20.67M | 3 month · $397.00K 6 month · $864.00K | 6 month · $-1.00K | (m) | (m) | (m) |
| 2026-03-31 | $198.92M | $-175.18M | $23.75M | 3 month · $467.00K | 3 month · $-1.00K | (m) | (m) | (m) |
| 2025-12-31 | $198.46M | $-171.33M | $27.13M | 12 month · $3.42M | (m) | (m) | (m) | (m) |
| 2025-09-30 | $197.04M | $-167.59M | $29.45M | 3 month · $688.00K 9 month · $2.78M | (m) | (m) | (m) | (m) |
| 2025-06-30 | $196.11M | $-163.05M | $33.06M | 3 month · $1.44M 6 month · $2.10M | (m) | (m) | (m) | (m) |
| 2025-03-31 | $194.66M | $-156.36M | $38.31M | 3 month · $651.00K | (m) | (m) | (m) | (m) |
| 2024-12-31 | $194.01M | $-151.85M | $42.16M | 12 month · $4.14M | (m) | (m) | (m) | (m) |
| 2024-09-30 | $193.00M | $-145.63M | $47.37M | 3 month · $1.00M 9 month · $3.12M | (m) | (m) | (m) | (m) |
| 2024-06-30 | $178.40M | $-139.98M | $38.42M | 3 month · $1.00M 6 month · $2.12M | (m) | (m) | (m) | (m) |
| 2024-03-31 | $177.40M | $-135.03M | $42.37M | 3 month · $1.11M | (m) | (m) | (m) | (m) |
| 2023-12-31 | $176.24M | $-130.04M | $46.20M | 12 month · $5.20M | (m) | (m) | (m) | (m) |
| 2023-09-30 | $149.30M | $-124.39M | $24.91M | 3 month · $1.10M 9 month · $4.05M | (m) | (m) | (m) | (m) |
| 2023-06-30 | $148.20M | $-119.39M | $28.81M | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $147.04M | $-112.91M | $34.13M | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $145.25M | $-106.52M | $38.73M | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | $143.01M | $-100.34M | $42.67M | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $140.80M | $-94.24M | $46.56M | 3 month · $2.24M | (m) | (m) | (m) | 3 month · $65.00K |
| 2022-03-31 | $138.50M | $-87.18M | $51.32M | 3 month · $2.24M | (m) | (m) | (m) | (m) |
| 2021-12-31 | $136.25M | $-81.85M | $54.40M | (m) | (m) | (m) | $95.00 | 12 month · $212.00K |
| 2021-09-30 | $130.92M | $-72.86M | $58.05M | (m) | (m) | (m) | $95.00 | (m) |
| 2021-06-30 | $111.35M | $-70.47M | $40.87M | 3 month · $203.00K | (m) | (m) | $85.00 | (m) |
| 2021-03-31 | $111.11M | $-68.10M | $43.01M | 3 month · $107.00K | (m) | (m) | $85.00 | 3 month · $212.00K |
| 2020-12-31 | $72.42M | $-65.32M | $7.10M | (m) | (m) | (m) | $25.00 | (m) |
| 2020-09-30 | $65.74M | $-60.95M | $4.79M | (m) | (m) | $42.00 | $403.00 | (m) |
| 2020-06-30 | $59.34M | $-58.97M | $369.45K | (m) | (m) | (m) | $240.00 | (m) |
| 2020-03-31 | $57.33M | $-57.35M | $-14.62K | (m) | (m) | (m) | $192.00 | 3 month · $14.07K |
| 2019-12-31 | $57.18M | $-56.19M | $989.94K | (m) | (m) | (m) | $7.00 | 12 month · $30.50K |
| 2019-09-30 | $56.98M | $-53.90M | $3.08M | (m) | (m) | (m) | $179.00 | (m) |
| 2019-06-30 | $56.73M | $-52.08M | $4.65M | (m) | (m) | (m) | $179.00 | 3 month · $28.16K |
| 2019-03-31 | $53.00M | $-50.14M | $2.87M | (m) | (m) | (m) | $141.00 | 3 month · $2.33K |
| 2018-12-31 | $50.60M | $-48.56M | $2.04M | (m) | (m) | (m) | $117.00 | 12 month · $179.00K |
| 2018-09-30 | $50.32M | $-46.78M | $3.54M | (m) | (m) | (m) | $117.00 | (m) |
| 2018-06-30 | $49.92M | $-45.31M | $4.61M | (m) | (m) | (m) | $117.00 | 3 month · $179.00K |
| 2018-03-31 | (m) | (m) | $-15.74M | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $24.39M | $-35.52M | $-11.13M | (m) | (m) | (m) | $61.00 | (m) |
| 2016-12-31 | (m) | (m) | $-4.22M | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |